These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

823 related items for PubMed ID: 18707731

  • 1. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
    Barocas DA, Cowan JE, Smith JA, Carroll PR, CaPSURE Investigators.
    J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
    [Abstract] [Full Text] [Related]

  • 2. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
    Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR.
    J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
    [Abstract] [Full Text] [Related]

  • 3. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
    Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
    [Abstract] [Full Text] [Related]

  • 4. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [Abstract] [Full Text] [Related]

  • 5. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.
    Reese AC, Cooperberg MR, Carroll PR.
    J Urol; 2010 Jul; 184(1):114-9. PubMed ID: 20478578
    [Abstract] [Full Text] [Related]

  • 6. Active surveillance for the management of prostate cancer in a contemporary cohort.
    Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR.
    Cancer; 2008 Jun 15; 112(12):2664-70. PubMed ID: 18433013
    [Abstract] [Full Text] [Related]

  • 7. Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era.
    Ercole B, Marietti SR, Fine J, Albertsen PC.
    J Urol; 2008 Oct 15; 180(4):1336-9; discussion 1340-1. PubMed ID: 18707696
    [Abstract] [Full Text] [Related]

  • 8. Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics.
    Krakowsky Y, Loblaw A, Klotz L.
    J Urol; 2010 Jul 15; 184(1):131-5. PubMed ID: 20478589
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prostate brachytherapy: a descriptive analysis from CaPSURE.
    Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR, CaPSURE Investigators.
    Brachytherapy; 2007 Jul 15; 6(2):123-8. PubMed ID: 17434105
    [Abstract] [Full Text] [Related]

  • 11. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.
    J Urol; 2005 Apr 15; 173(4):1126-31. PubMed ID: 15758720
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators.
    Prostate Cancer Prostatic Dis; 2008 Apr 15; 11(3):280-7. PubMed ID: 17893700
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
    Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR.
    Urology; 2007 Jul 15; 70(1):106-10. PubMed ID: 17656218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR, Bird VY, Deorah S, Dahmoush L.
    J Urol; 2005 Nov 15; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM, Porter MP, Soloway MS.
    J Urol; 2008 Nov 15; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.